BRPI0514860A - fenóis de fenantridina carbonila - Google Patents
fenóis de fenantridina carbonilaInfo
- Publication number
- BRPI0514860A BRPI0514860A BRPI0514860-0A BRPI0514860A BRPI0514860A BR PI0514860 A BRPI0514860 A BR PI0514860A BR PI0514860 A BRPI0514860 A BR PI0514860A BR PI0514860 A BRPI0514860 A BR PI0514860A
- Authority
- BR
- Brazil
- Prior art keywords
- phenanthridine
- carbonyl
- phenols
- phenanthridine carbonyl
- carbonyl phenols
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/10—Aza-phenanthrenes
- C07D221/12—Phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
FENóIS DE FENANTRIDINA CARBONILA A presente invenção fornece composições e compostos de fenantridina carbonila, particularmente aqueles que encontram uso como ligandos para o receptor de estrogênio. Os composto representativos da invenção incluem aqueles da fórmula I.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60678404P | 2004-09-02 | 2004-09-02 | |
PCT/US2005/031053 WO2006028875A1 (en) | 2004-09-02 | 2005-08-30 | Phenanthridine carbonyl phenols as cytokine modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0514860A true BRPI0514860A (pt) | 2008-06-24 |
Family
ID=35447362
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0514860-0A BRPI0514860A (pt) | 2004-09-02 | 2005-08-30 | fenóis de fenantridina carbonila |
Country Status (19)
Country | Link |
---|---|
US (1) | US7585871B2 (pt) |
EP (1) | EP1784391A1 (pt) |
JP (1) | JP2008511666A (pt) |
KR (1) | KR20070051877A (pt) |
CN (1) | CN101052623A (pt) |
AR (1) | AR050719A1 (pt) |
AU (1) | AU2005282829A1 (pt) |
BR (1) | BRPI0514860A (pt) |
CA (1) | CA2578933A1 (pt) |
CR (1) | CR8946A (pt) |
EC (1) | ECSP077366A (pt) |
IL (1) | IL181585A0 (pt) |
MX (1) | MX2007002624A (pt) |
NI (1) | NI200700066A (pt) |
NO (1) | NO20071439L (pt) |
RU (1) | RU2007108713A (pt) |
TW (1) | TW200616629A (pt) |
WO (1) | WO2006028875A1 (pt) |
ZA (1) | ZA200702701B (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102532148B (zh) * | 2011-12-22 | 2014-11-12 | 华中科技大学 | 葱莲中具有抗肿瘤作用的化合物及其分离制备方法和应用 |
EP3551636A4 (en) * | 2016-12-06 | 2019-12-25 | Valorbec, Société en Commandite | THIENOISOCHINOLINE AND THEIR DERIVATIVES FOR TREATING CANCER |
JP7061772B2 (ja) * | 2018-05-18 | 2022-05-02 | 国立大学法人千葉大学 | フェナントリジン化合物の製造方法 |
WO2020117894A1 (en) * | 2018-12-05 | 2020-06-11 | The Board Of Trustees Of The University Of Illinois | Isocarbostyril alkaloids and functionalization thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4206225A (en) | 1978-09-22 | 1980-06-03 | Pfizer Inc. | 2,10-Disubstituted dibenzo[b,d]pyrans and benzo[c]quinolines |
US4228169A (en) * | 1979-06-26 | 1980-10-14 | Pfizer Inc. | 1,9-Dihydroxyoctahydrobenzo[c]quinolines and 1-hydroxyhexahydrobenzo[c]quinoline-9(8H)-ones as antiemetic agents |
US5869483A (en) * | 1993-07-29 | 1999-02-09 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
AU2001281965A1 (en) | 2000-07-14 | 2002-01-30 | Byk Gulden Lomberg Chemische Fabrik G.M.B.H. | Novel 6-phenylphenanthridines |
UA83620C2 (ru) * | 2001-12-05 | 2008-08-11 | Уайт | Замещенные бензоксазолы и их аналоги как эстрогенные агенты |
TW200409759A (en) * | 2002-09-25 | 2004-06-16 | Wyeth Corp | Substituted 4-(indazol-3-yl)phenols |
US6894061B2 (en) * | 2002-12-04 | 2005-05-17 | Wyeth | Substituted dihydrophenanthridinesulfonamides |
-
2005
- 2005-08-30 TW TW094129653A patent/TW200616629A/zh unknown
- 2005-08-30 CA CA002578933A patent/CA2578933A1/en not_active Abandoned
- 2005-08-30 AR ARP050103633A patent/AR050719A1/es not_active Application Discontinuation
- 2005-08-30 MX MX2007002624A patent/MX2007002624A/es active IP Right Grant
- 2005-08-30 JP JP2007530331A patent/JP2008511666A/ja active Pending
- 2005-08-30 KR KR1020077005155A patent/KR20070051877A/ko not_active Application Discontinuation
- 2005-08-30 EP EP05793519A patent/EP1784391A1/en not_active Withdrawn
- 2005-08-30 AU AU2005282829A patent/AU2005282829A1/en not_active Abandoned
- 2005-08-30 RU RU2007108713/04A patent/RU2007108713A/ru not_active Application Discontinuation
- 2005-08-30 US US11/215,333 patent/US7585871B2/en not_active Expired - Fee Related
- 2005-08-30 WO PCT/US2005/031053 patent/WO2006028875A1/en active Application Filing
- 2005-08-30 CN CNA2005800377153A patent/CN101052623A/zh active Pending
- 2005-08-30 BR BRPI0514860-0A patent/BRPI0514860A/pt not_active IP Right Cessation
-
2007
- 2007-02-27 CR CR8946A patent/CR8946A/es not_active Application Discontinuation
- 2007-02-27 IL IL181585A patent/IL181585A0/en unknown
- 2007-02-28 NI NI200700066A patent/NI200700066A/es unknown
- 2007-03-16 NO NO20071439A patent/NO20071439L/no not_active Application Discontinuation
- 2007-03-30 ZA ZA200702701A patent/ZA200702701B/xx unknown
- 2007-04-02 EC EC2007007366A patent/ECSP077366A/es unknown
Also Published As
Publication number | Publication date |
---|---|
NO20071439L (no) | 2007-04-23 |
US7585871B2 (en) | 2009-09-08 |
IL181585A0 (en) | 2007-07-04 |
MX2007002624A (es) | 2007-04-27 |
CR8946A (es) | 2007-10-04 |
ZA200702701B (en) | 2009-10-28 |
TW200616629A (en) | 2006-06-01 |
CN101052623A (zh) | 2007-10-10 |
RU2007108713A (ru) | 2008-10-10 |
CA2578933A1 (en) | 2006-03-16 |
AR050719A1 (es) | 2006-11-15 |
US20060058337A1 (en) | 2006-03-16 |
NI200700066A (es) | 2008-02-14 |
ECSP077366A (es) | 2007-05-30 |
EP1784391A1 (en) | 2007-05-16 |
WO2006028875A1 (en) | 2006-03-16 |
KR20070051877A (ko) | 2007-05-18 |
JP2008511666A (ja) | 2008-04-17 |
AU2005282829A1 (en) | 2006-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6321189A2 (es) | Compuestos de tiazol y oxazol de bencen-sulfonamida | |
CR11861A (es) | Compuestos organicos | |
CR9786A (es) | Compuestos de bencimidazol-tiofeno | |
DOP2015000264A (es) | Derivados de azaadamantano y métodos de uso de los mismos | |
CR10548A (es) | 18-metil-19nor-androst-4-en-17, 17-espiroeteres (18-metil-19-nor-20-espirox-4-en-3-onas) asi como preparaciones farmaceuticas que los contienen | |
BRPI0720972B8 (pt) | compostos análogos de ciclopamina e composições farmacêuticas compreendendo os referidos compostos | |
CR10157A (es) | Compuestos químicos | |
CL2008002521A1 (es) | Compuestos derivados de pirazol sustituidos, antagonista del receptor de androgeno; composicion farmaceutica que comprende a dichos compuestos; y uso del compusto para el tratamiento de cancer. | |
BRPI0922364A2 (pt) | Composto, composição farmacêutica e uso de um composto | |
BRPI0520870B8 (pt) | compostos intermediários para a preparação de alfa-mercaptoacetanilidas de s-triazolila | |
CR9223A (es) | 18-metil-19-nor-17-pregn-4-en-21, 17-carbolactonas,asi como preparaciones farmaceuticas que las contienen | |
UY31688A1 (es) | Plaguicidas | |
CR8986A (es) | Isoxazoles sustituidos como fungicidas | |
CL2007003138A1 (es) | Compuestos derivados de anilinopiperazina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer. | |
CL2007003244A1 (es) | Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer. | |
CO6571883A2 (es) | Composición pesticida y su uso | |
HN2008001723A (es) | Nitrilos espirociclicos como inhibidores de proteasa | |
UY32659A (es) | Pirazinilpirazoles | |
DOP2006000069A (es) | Nuevos compuestos farmaceuticos. | |
CY1115196T1 (el) | Αντικαρκινικος παραγων | |
GT201000047A (es) | Mejoras en compuestos organicos o relacionadas con los mismos | |
ATE459620T1 (de) | Benzimidazolthiophenverbindungen als plk- modulatoren | |
AR058127A1 (es) | Derivados de piperidina antagonistas de cgrp, procedimientos para su preparacion asi como su uso como medicamentos | |
CR10344A (es) | 2-(piridin)-2-il)-pirimidinas como fungicidas | |
CO6571898A2 (es) | Composición pesticida y su uso |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2166 DE 10/07/2012. |